Validation of MiROvaR, a microRNA-based predictor of early relapse in early stage epithelial ovarian cancer as a new strategy to optimise patients' prognostic assessment.
暂无分享,去创建一个
S. Pignata | A. Tomassetti | L. De Cecco | G. Bogani | B. Paolini | P. Chiodini | D. Mezzanzanica | M. Bagnoli | P. Alberti | U. Leone Roberti Maggiore | F. Raspagliesi | A. Ditto | F. Martinelli